EPHA2 and neoplasm: Although, the mechanism by which cancer cells escape ligand-dependent tumor-suppressive signaling in vivo remains unclear, we have recently elucidated a novel molecular mechanism that regulates the conflicting cellular functions of EphA2 signaling (14).